Skip to content
Adam Torkildson – Lifestyle
Author:
Juniper Biosciences
Juniper Biosciences Builds Clinical and Commercial Leadership Teams with Appointments of Deepak Behera, M.D., as Chief Medical Officer, Javed Mahmood, Ph.D., as Senior Director of Clinical Development, and Robert Sgroi as Chief Commercial Officer
November 11, 2026
Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026
September 15, 2026
Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer
September 1, 2026
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026